A-PReP - Oral Therapies - On Demand Webinar
WebcastFaculty
OVERVIEW
A-PReP - Oral Therapies - On Demand Webinar is organized by National Psoriasis Foundation (NPF) and will be held from Oct 06, 2018 - Apr 04, 2020.
The target audience for this medical event is physicians, physician assistants and nurse practitioners. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit.
The Allied Healthcare Recognition Provider Program is designed to help enhance your skills in caring for those with psoriasis. After completing the full program, attendees will be formally recognized as up-to-date in the latest psoriasis treatment.
Conference Objectives:
After completing this activity, participants should be able to:
• Discuss evolving understanding on the pathophysiology of psoriasis, including identification of targets for therapy.
• Apply guideline-based criteria to the diagnosis and assessment of psoriasis.
• Select appropriate therapies for moderate to severe psoriasis based on current evidence for efficacy, safety and adherence.
• Describe the role of early intervention and referral in psoriasis, including the use of goal-oriented strategies in monitoring outcomes from therapy.
• Outline the spectrum of comorbidities associated with psoriasis and institute treatment plans aimed at minimizing their impact.
Additional details will be posted as soon as they are available.
The target audience for this medical event is physicians, physician assistants and nurse practitioners. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit.
The Allied Healthcare Recognition Provider Program is designed to help enhance your skills in caring for those with psoriasis. After completing the full program, attendees will be formally recognized as up-to-date in the latest psoriasis treatment.
Conference Objectives:
After completing this activity, participants should be able to:
• Discuss evolving understanding on the pathophysiology of psoriasis, including identification of targets for therapy.
• Apply guideline-based criteria to the diagnosis and assessment of psoriasis.
• Select appropriate therapies for moderate to severe psoriasis based on current evidence for efficacy, safety and adherence.
• Describe the role of early intervention and referral in psoriasis, including the use of goal-oriented strategies in monitoring outcomes from therapy.
• Outline the spectrum of comorbidities associated with psoriasis and institute treatment plans aimed at minimizing their impact.
Additional details will be posted as soon as they are available.
SPECIALITIES
DermatologyRELATED ONLINE COURSES
Quick Links